These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7872342)

  • 41. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension.
    Yasumoto K; Takata M; Ueno H; Tomita S; Tomoda F; Inoue H
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):921-4. PubMed ID: 10509551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
    Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P
    J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
    Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy.
    Ogino K; Ogura K; Kinugawa T; Osaki S; Kato M; Furuse Y; Kinugasa Y; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Circ J; 2004 May; 68(5):444-50. PubMed ID: 15118286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between echocardiographic parameters and brain natriuretic peptide levels in treated hypertensive patients.
    Masugata H; Senda S; Murao K; Okuyama H; Inukai M; Hosomi N; Iwado Y; Noma T; Kohno M; Goda F
    Clin Exp Hypertens; 2011; 33(3):187-91. PubMed ID: 21446893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
    Sato A; Suzuki Y; Saruta T
    Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure.
    Sakata Y; Yamamoto K; Masuyama T; Mano T; Nishikawa N; Kuzuya T; Miwa T; Hori M
    J Hypertens; 2001 Oct; 19(10):1905-12. PubMed ID: 11593113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
    Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
    Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.
    Cherchi A; Sau F; Seguro C
    J Clin Hypertens; 1987 Jun; 3(2):216-25. PubMed ID: 2886561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain natriuretic peptide as a cardiac hormone in essential hypertension.
    Kohno M; Horio T; Yokokawa K; Murakawa K; Yasunari K; Akioka K; Tahara A; Toda I; Takeuchi K; Kurihara N
    Am J Med; 1992 Jan; 92(1):29-34. PubMed ID: 1530996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension.
    Tsioufis C; Stougiannos P; Taxiarchou E; Skiadas I; Chatzis D; Thomopoulos C; Lalos S; Stefanadis C; Kallikazaros I
    J Hypertens; 2006 May; 24(5):965-72. PubMed ID: 16612260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natriuretic peptides in sheep with pressure overload left ventricular hypertrophy.
    Charles CJ; Kaaja RJ; Espiner EA; Nicholls MG; Pemberton CJ; Richards AM; Yandle TG
    Clin Exp Hypertens; 1996 Nov; 18(8):1051-71. PubMed ID: 8922345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
    Ueno H; Takata M; Tomita S; Oh-hashi S; Yasumoto K; Inoue H
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):643-8. PubMed ID: 9388047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial and brain natriuretic peptides: secretion during exercise in patients with essential hypertension and modulation by acute angiotensin-converting enzyme inhibition.
    Kohno M; Horio T; Yokokawa K; Murakawa K; Yasunari K; Kurihara N; Takeda T
    Clin Exp Pharmacol Physiol; 1992 Mar; 19(3):193-200. PubMed ID: 1387838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients.
    Nakamura M; Tanaka F; Yonezawa S; Satou K; Nagano M; Hiramori K
    Am J Hypertens; 2003 Dec; 16(12):1025-9. PubMed ID: 14643576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors.
    Paoletti E; Cassottana P; Bellino D; Specchia C; Messa P; Cannella G
    Am J Kidney Dis; 2002 Oct; 40(4):728-36. PubMed ID: 12324907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events.
    Suzuki M; Hamada M; Yamamoto K; Kazatani Y; Hiwada K
    Hypertens Res; 2002 Sep; 25(5):669-76. PubMed ID: 12452317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.